Effective graft vs leukemia effects independently of graft vs host disease following T-cell depleted allogeneic bone marrow transplantation in a murine model of B-cell leukemia/lymphoma (BCL1): Role of cell therapy and rIL-2
Weiss L, Lubin I, Factorowich I, et al. Effective graft vs leukemia effects independently of graft vs host disease following T-cell depleted allogeneic bone marrow transplantation in a murine model of B-cell leukemia/lymphoma (BCL1): role of cell therapy and rIL-2. J Immunol 1994; 153: 2562.
Characterization of effector cells of graft vs leukemia (GVL) following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia (BCL1)
Weiss L, Weigensberg M, Morecki S, et al. Characterization of effector cells of graft vs leukemia (GVL) following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia (BCL1). Cancer Immunol Immunother 1990; 31: 236.
Selective depletion of marrow T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation
Maraninchi D, Mawas C, Guyotat D, et al. Selective depletion of marrow T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Transpl Int 1988; 1: 91.
Acute lethal graftversus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones
Lehmann PV, Schumm G, Moon D, et al. Acute lethal graftversus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones. J Exp Med 1990; 171: 1485.
T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin-2
Malkovsky M, Brenner MK, Hunt R, et al. T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin-2. Cell Immunol 1986; 103: 476.
Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed to T cells or their subsets
Knulst AC, Noort WA, Tibbe GJM, Benner R, Savelkoul HFJ. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed to T cells or their subsets. Bone Marrow Transplant 1994; 14: 535.
+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. 1995; 86: 2821.
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer
Kennedy M, Vogelsang G, Jones R, et al. Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1994; 12: 249.
Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences
Sprent J, Schaefer M, Korngold R. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. J Immunol 1990; 144: 2946.